Pnictogen-containing heterocyclic compounds and their use

US12564636B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12564636-B2
Application numberUS-202318106242-A
CountryUS
Kind codeB2
Filing dateFeb 6, 2023
Priority dateMar 26, 2022
Publication dateMar 3, 2026
Grant dateMar 3, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are pnictogen-containing heterocyclic compounds of Formula (I) Each of R1, the heterocyclic ring H, A+, LG, and X− is defined herein. Also provided are methods of modifying a substrate using such a compound, conjugated biomolecules thus modified, and pharmaceutical compositions containing one of the conjugated biomolecules.

First claim

Opening claim text (preview).

What is claimed is: 1 . A pnictogen-containing heterocyclic compound of Formula (I): in which R 1 is C 1 -C 6 alkyl, C4-C10 cycloalkyl, 5- to 8-membered heterocycloalkyl, aryl, or heteroaryl;  is a heterocyclic ring; A + is a cationic quaternary pnictogen atom; LG is a leaving group selected from the group consisting of halogen, aryloxy, R a O 2 S—, R b O 2 S—O—, R c OS—, R d S(O)(NSO 2 R e )—, and R f S(O)(N + (CH 3 ) 2 )-, each of R a , R b , R c , R d , R e , and R f , independently, being C 1 -C 6 alkyl, aryl, heteroaryl, halogen, alkoxy, or aryloxy; X − is a counter anion selected from the group consisting of halide, polyhalide anion, perchlorate, hydroxide, peroxide, siloxide, sulfate, hydrogen sulfate, sulfite, disulfite, dithionate, dithionite, halosulfate, thiosulfate, persulfate, disulfate, sulfinate (R′SO 2 − ), sulfonate (R″SO 3 − ), bis(sulfonyl)imide ((R′SO 2 ) 2 N − ), nitrate, nitrite, azide, cyanide, cyanate, thiocyanate, phosphate, metaphosphate, polyphosphate, hydrogen phosphate, dihydrogen phosphate, monohalophosphate, dihalophosphate, hexahalophosphate, organophosphonate (R′P(O)(O − ) 2 or R′P(O)(OR − ) (O − )), organophosphate (R′OP(O)(O) 2 or R′OP(O)(OR″)(O − )), arsenate, alkoxide, alkenoxide, aryloxide, carboxylate, percarboxylate, carbonate, bicarbonate, oxalate, borate, tetrahaloborate, tetraalkylborate, tetraarylborate, carborane, and combinations thereof, each of R′ and R″, independently, being C 1 -C 6 alkyl or aryl; and the number of net negative charges of X″ equals to that of the net positive charges of 2 . The pnictogen-containing heterocyclic compound of claim 1 , wherein the compound is a compound of Formula (II): in which the cationic quaternary pnictogen atom is N + in Formula (II); R 1 is CH 3 , CH 2 CH 3 or -L-Het + ; each of R 2 , R 3 , R 4 , R 5 , and R 6 , independently, is H, F, Cl, Br, I, C 1 -C 10 alkoxy, R a O 2 S—, R b O 2 S—O—, R f S(O)(N + (CH 3 ) 2 )—, halogenated aryl, halogenated heteroaryl, Het + , or -L-Het + , in which Het + is  R 1 ′ is CH 3 or CH 2 CH 3 ; each of R 2 ′, R 3 ′, R 4 ′, R 5 ′, and R 6 ′, independently, is H, NO 2 , F, Cl, Br, I, R a ′O 2 S—, R b ′O 2 S—O—, or R f S(O)(N + (CH 3 ) 2 )—; each of R a ′, R b ′, and R f ′, independently, is C 1 -C 6 alkyl or aryl; and X′ is a counter anion selected from the group consisting of halide, polyhalide anion, perchlorate, hydroxide, peroxide, siloxide, sulfate, hydrogen sulfate, sulfite, disulfite, dithionate, dithionite, halosulfate, thiosulfate, persulfate, disulfate, sulfinate (R′SO 2 − ), sulfonate (R″SO 3 − ), bis(sulfonyl)imide ((R′SO 2 ) 2 N − ), nitrate, nitrite, azide, cyanide, cyanate, thiocyanate, phosphate, metaphosphate, polyphosphate, hydrogen phosphate, dihydrogen phosphate, monohalophosphate, dihalophosphate, hexahalophosphate, organophosphonate (R′P(O)(O − ) 2 or R′P(O)(OR″)(O − )), organophosphate (R′OP(O)(O − ) 2 or R′OP(O)(OR″)(O − )), arsenate, alkoxide, alkenoxide, aryloxide, carboxylate, percarboxylate, carbonate, bicarbonate, oxalate, borate, tetrahaloborate, tetraalkylborate, tetraarylborate, carborane, and combinations thereof, each of R′ and R″, independently, being C 1 -C 6 alkyl or aryl; L is a linker selected from the group consisting of  n is an integer from 0 to 20; R g is C 1 -C 6 alkyl; and Ar is aryl; at least one of R 2 , R 3 , R 4 , R 5 , and R 6 is the leaving group that is F, Cl, Br, I, R a O 2 S—, or R b O 2 S—O—; when R 2 is F, (i) R 4 is F, Cl, Br, I, C 1 -C 10 alkoxy, R a O 2 S—, or R b O 2 S—O—, (ii) R 5 is NO 2 , or (iii) one and only one of R 3 , R 4 , R 5 , and R 6 is Het + ; when R 2 is Cl, R 5 is H or Het + ; and when R 4 is-SO 2 CH 3 , (i) R 2 is F, Cl, Br, I, C 1 -C 10 alkoxy, R a O 2 S—, or R b O 2 S—O—, or (ii) one and only one of R 2 , R 3 , R 5 , and R 6 is Het + . 3 . The pnictogen-containing heterocyclic compound of claim 2 , wherein at least one of R 2 , R 4 , and R 6 is the leaving group. 4 . The pnictogen-containing heterocyclic compound of claim 3 , wherein the leaving group is F or CH 3 O 2 S—. 5 . The pnictogen-containing heterocyclic compound of claim 2 , wherein R 2 , being the leaving group, is CH 3 O 2 S—, and R 4 is H, C 1 -C 10 alkoxy, or Het + . 6 . The pnictogen-containing heterocyclic compound of claim 2 , wherein R 1 is methyl or ethyl. 7 . The pnictogen-containing heterocyclic compound of claim 2 , wherein R 3 or R 5 is NO 2 . 8 . The pnictogen-containing heterocyclic compound of claim 2 , wherein the compound is a compound of Formula (III): in which one and only one of B, D, and E is N + CH 3 or N + CH 2 CH 3 ; one and only one of B, D, and E is CR 2 , R 2 being F, Cl, Br, I, R a O 2 S—, or R b O 2 S—O—; one and only one of B, D, and E is CR 11 , R 11 being C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl amino, C 4 -C 10 cycloalkyl, C 4 -C 10 cycloalkoxy, 5- to 8-membered heterocycloalkyl, 5- to 8-membered heterocycloalkoxy, aryl, aryloxy, heteroaryl, or heteroaryloxy; one and only one of B′, D′, and E′ is N + CH 3 or N + CH 2 CH 3 ; one and only one of B′, D′, and E′ is CR 2 ′, R 2 ′ being F, Cl, Br, I, R a ′O 2 S—, or R b ′O 2 S—O—; one and only one of B′, D′, and E′ is CR 11 ′, R 11 ′ being C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl amino, C 4 -C 10 cycloalkyl, C 4 -C 10 cycloalkoxy, 5- to 8-membered heterocycloalkyl, 5- to 8-membered heterocycloalkoxy, aryl, aryloxy, heteroaryl, or heteroaryloxy; and X′ − is a counter anion selected from the group consisting of halide, polyhalide anion, perchlorate, hydroxide, peroxide, siloxide, sulfate, hydrogen sulfate, sulfite, disulfite, dithionate, dithionite, halosulfate, thiosulfate, persulfate, disulfate, sulfinate (R′SO 2 − ), sulfonate (R″SO 3 − ), bis(sulfonyl)imide ((R′SO 2 ) 2 N − ), nitrate, nitrite, azide, cyanide, cyanate, thiocyanate, phosphate, metaphosphate, polyphosphate, hydrogen phosphate, dihydrogen phosphate, monohalophosphate, dihalophosphate, hexahalophosphate, organophosphonate (R′P(O)(O − ) 2 or R′P(O)(OR″)(O − )), organophosphate (R′OP(O)(O − ) 2 or R′OP(O)(OR″)(O − )), arsenate, alkoxide, alkenoxide, aryloxide, carboxylate, percarboxylate, carbonate, bicarbonate, oxalate, borate, tetrahaloborate, tetraalkylborate, tetraarylborate, carborane, and combinations thereof, each of R′ and R″, independently, being C 1 -C 6 alkyl or aryl. 9 . The pnictogen-containing heterocyclic compound of claim 8 , wherein each of R 2 and R 2 ′, independently, is F or CH 3 O 2 S—. 10 . The pnictogen-containing heterocyclic compound of claim 1 , wherein the compound is a compound of Formula (IV):

Assignees

Inventors

Classifications

  • Benzothiazoles · CPC title

  • Halogen atoms or nitro radicals · CPC title

  • Halogen atoms or nitro radicals · CPC title

  • Sulfur atoms · CPC title

  • with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12564636B2 cover?
Disclosed are pnictogen-containing heterocyclic compounds of Formula (I) Each of R1, the heterocyclic ring H, A+, LG, and X− is defined herein. Also provided are methods of modifying a substrate using such a compound, conjugated biomolecules thus modified, and pharmaceutical compositions containing one of the conjugated biomolecules.
Who is the assignee on this patent?
Univ Of Rhode Island Board Of Trustees, Colgate Univ
What technology area does this patent fall under?
Primary CPC classification C07D213/68. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).